These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 1974505

  • 1. Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
    Widmann L, van der Does R, Hörrmann M, Machwirth M.
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S143-6. PubMed ID: 1974505
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide.
    van der Does R, Widmann L, Uberbacher HJ, Hörrmann M, Machwirth M, Stienen U.
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S147-52. PubMed ID: 1974506
    [Abstract] [Full Text] [Related]

  • 3. The safety of adding carvedilol to hypertensive patients inadequately treated with diuretics.
    Dupont AG, Schoors DF, Venuti RP.
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S153-7. PubMed ID: 1974507
    [Abstract] [Full Text] [Related]

  • 4. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
    Ruilope LM.
    Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
    Ollivier JP, Durier P, Bussiere JL, Gayet JL.
    Eur J Clin Pharmacol; 1990 Feb; 38 Suppl 2():S164-6. PubMed ID: 1974509
    [Abstract] [Full Text] [Related]

  • 6. A multicenter comparison of carvedilol with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension.
    Langdon CG, Baxter GA, Young PH.
    J Cardiovasc Pharmacol; 1991 Feb; 18 Suppl 4():S51-6. PubMed ID: 1721980
    [Abstract] [Full Text] [Related]

  • 7. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
    Mori Y, Nishikawa Y, Iizuka T, Zenimura N, Matsumoto T, Hiramatsu K, Komiya M.
    Drugs R D; 2011 Feb; 11(2):171-90. PubMed ID: 21679007
    [Abstract] [Full Text] [Related]

  • 8. Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study.
    Freytag F, Schelling A, Meinicke T, Deichsel G, Telmisartan Hypertension Experience in a Randomized European Study Versus Atenolol Study Group.
    Clin Ther; 2001 Jan; 23(1):108-23. PubMed ID: 11219471
    [Abstract] [Full Text] [Related]

  • 9. Carvedilol and atenolol once daily in the treatment of hypertension.
    Luurila OJ, Härkönen R, Hilden M, Icen R, Kohvakka A, Linna M, Sillanpää J, Vänskä O, Lukkala K.
    J Hypertens Suppl; 1989 Dec; 7(6):S264-5. PubMed ID: 2576666
    [Abstract] [Full Text] [Related]

  • 10. A comparison of carvedilol with atenolol in the treatment of mild-to-moderate essential hypertension. INT-CAR-07 (U.K.) Study Group.
    Young PH.
    J Cardiovasc Pharmacol; 1992 Dec; 19 Suppl 1():S82-5. PubMed ID: 1378155
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive and metabolic effects of single and combined atenolol regimens.
    Chrysant SG, Chappel C, Farnham DJ, Levin B, Lueg M, McCluskey D, Steiner C.
    J Clin Pharmacol; 1992 Jan; 32(1):61-5. PubMed ID: 1740538
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study Group.
    Os I, Hotnes T, Dollerup J, Mogensen CE.
    Am J Hypertens; 1997 Aug; 10(8):899-904. PubMed ID: 9270085
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of carvedilol in mild to moderate essential hypertension and effects on microalbuminuria: a multicenter, randomized, open-label, controlled study versus atenolol.
    Marchi F, Ciriello G.
    Adv Ther; 1995 Aug; 12(4):212-21. PubMed ID: 10155349
    [Abstract] [Full Text] [Related]

  • 14. Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study.
    McPhillips JJ, Schwemer GT, Scott DI, Zinny M, Patterson D.
    Drugs; 1988 Aug; 36 Suppl 6():82-91. PubMed ID: 2908306
    [Abstract] [Full Text] [Related]

  • 15. Comparison of acebutolol with and without hydrochlorothiazide versus carvedilol with and without hydrochlorothiazide in black patients with mild to moderate systemic hypertension.
    Radevski IV, Valtchanova SP, Candy GP, Tshele EF, Sareli P.
    Am J Cardiol; 1999 Jul 01; 84(1):70-5. PubMed ID: 10404854
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of carvedilol in renal hypertension. A multicenter open trial.
    Takeda T, Kohno M, Ishii M, Kubo S, Saruta T, Mizuno Y, Fukiyama K, Fujishima M, Yoshimura M.
    Eur J Clin Pharmacol; 1990 Jul 01; 38 Suppl 2():S158-63. PubMed ID: 1974508
    [Abstract] [Full Text] [Related]

  • 17. A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension.
    Oparil S, Abate N, Chen E, Creager MA, Galet V, Jia G, Julius S, Lerman A, Lyle PA, Pool J, Tershakovec AM.
    Curr Med Res Opin; 2008 Apr 01; 24(4):1101-14. PubMed ID: 18328120
    [Abstract] [Full Text] [Related]

  • 18. The efficacy and tolerability of losartan versus atenolol in patients with isolated systolic hypertension. Losartan ISH Investigators Group.
    Farsang C, Garcia-Puig J, Niegowska J, Baiz AQ, Vrijens F, Bortman G.
    J Hypertens; 2000 Jun 01; 18(6):795-801. PubMed ID: 10872566
    [Abstract] [Full Text] [Related]

  • 19. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW, Laugerotte A, Wright JM.
    Cochrane Database Syst Rev; 2015 Aug 26; 2015(8):CD007449. PubMed ID: 26306578
    [Abstract] [Full Text] [Related]

  • 20. Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial study.
    Chrysant SG, Chavanu KJ, Xu J.
    Am J Cardiovasc Drugs; 2009 Aug 26; 9(4):241-51. PubMed ID: 19655819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.